Steven W Lefkowitz, a director at $CRMD, sold 40,000 shares of the company on 12-09-2025 for an estimated $475,200. We received data on the trade from a recent SEC filing. This was a sale of approximately 33.2% of their shares of this class of stock. Following this trade, they now own 80,498 shares of this class of $CRMD stock.
$CRMD Insider Trading Activity
$CRMD insiders have traded $CRMD stock on the open market 11 times in the past 6 months. Of those trades, 1 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $CRMD stock by insiders over the last 6 months:
- JANET DILLIONE has made 0 purchases and 3 sales selling 103,000 shares for an estimated $1,070,755.
- ELIZABETH HURLBURT (Chief Operating Officer) has made 0 purchases and 2 sales selling 53,997 shares for an estimated $711,817.
- KAUFMAN BETH ZELNICK (Chief Legal Officer) has made 0 purchases and 2 sales selling 50,000 shares for an estimated $670,264.
- JOSEPH TODISCO (Chief Executive Officer) sold 50,000 shares for an estimated $650,000
- STEVEN W LEFKOWITZ sold 40,000 shares for an estimated $475,200
- MYRON KAPLAN purchased 25,000 shares for an estimated $275,500
- ALAN W DUNTON sold 10,000 shares for an estimated $131,300
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CRMD Hedge Fund Activity
We have seen 141 institutional investors add shares of $CRMD stock to their portfolio, and 67 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DEERFIELD MANAGEMENT COMPANY, L.P. added 3,323,833 shares (+inf%) to their portfolio in Q3 2025, for an estimated $38,656,177
- ELLIOTT INVESTMENT MANAGEMENT L.P. removed 2,444,561 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $30,116,991
- MARSHALL WACE, LLP added 893,518 shares (+34.6%) to their portfolio in Q3 2025, for an estimated $10,391,614
- UBS GROUP AG added 814,964 shares (+295.3%) to their portfolio in Q3 2025, for an estimated $9,478,031
- JUMP FINANCIAL, LLC added 774,083 shares (+inf%) to their portfolio in Q3 2025, for an estimated $9,002,585
- NUVEEN, LLC removed 772,997 shares (-52.6%) from their portfolio in Q3 2025, for an estimated $8,989,955
- GHISALLO CAPITAL MANAGEMENT LLC removed 750,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $8,722,500
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CRMD Revenue
$CRMD had revenues of $104.3M in Q3 2025. This is an increase of 810.22% from the same period in the prior year.
You can track CRMD financials on Quiver Quantitative's CRMD stock page.
$CRMD Analyst Ratings
Wall Street analysts have issued reports on $CRMD in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 11/13/2025
- D. Boral Capital issued a "Buy" rating on 11/12/2025
- Needham issued a "Buy" rating on 11/12/2025
- RBC Capital issued a "Outperform" rating on 10/21/2025
- JMP Securities issued a "Market Outperform" rating on 09/09/2025
To track analyst ratings and price targets for $CRMD, check out Quiver Quantitative's $CRMD forecast page.
$CRMD Price Targets
Multiple analysts have issued price targets for $CRMD recently. We have seen 5 analysts offer price targets for $CRMD in the last 6 months, with a median target of $18.0.
Here are some recent targets:
- Brandon Folkes from HC Wainwright & Co. set a target price of $18.0 on 11/13/2025
- Jason Kolbert from D. Boral Capital set a target price of $14.0 on 11/12/2025
- Serge Belanger from Needham set a target price of $16.0 on 11/12/2025
- Leonid Timashev from RBC Capital set a target price of $22.0 on 10/21/2025
- Jason N. Butler from JMP Securities set a target price of $22.0 on 09/09/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
